DOCSLIB.ORG

Studies of Mucosal Immune Regulation in Celiac Disease and Type 1 Diabetes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Studies of Mucosal Immune Regulation in Celiac Disease and Type 1 Diabetes Linköping University Medical Dissertations No. 1410. STUDIES OF MUCOSAL IMMUNE REGULATION IN CELIAC DISEASE AND TYPE 1 DIABETES ANNE LAHDENPERÄ Division of Paediatrics Department of Clinical and Experimental Medicine Faculty of Health Sciences, Linköping University, Sweden Linköping 2014 © Anne Lahdenperä, 2014 ISBN: 978-91-7519-286-4. ISSN: 0345-0082. Paper I, II and III has been printed with permission from the publisher. During the course of the research underlying this thesis, Anne Lahdenperä was enrolled in Forum Scientium, a multidisciplinary doctoral programme at Linköping University, Sweden. Printed in Sweden by LiU-Tryck, Linköping, Sweden, 2014. II To my family III SUPERVISORS Johnny Ludvigsson, Professor Emeritus Division of Paediatrics, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden. Outi Vaarala, Professor Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland. Translational Science, Innovative Medicine/Respiratory, Inflammatory and Autoimmune Diseases, AstraZeneca. Rosaura Casas, Associate Professor Division of Paediatrics, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden. OPPONENT Eva Sverremark-Ekström, Professor The Wenner-Gren Institute, Department of Molecular Biosciences, Stockholm University, Stockholm, Sweden. COMMITTEE BOARD Marie-Louise Hammarström, Professor Immunology, Department of Clinical Microbiology, Umeå University, Umeå, Sweden. Jonas Wetterö, Associate Professor Autoimmunity and Immune Regulation Unit (AIR)/Rheumatology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden. Torbjörn Ledin, Professor Oto-Rhino-Laryngology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden. IV CONTENTS LIST OF ORIGINAL PAPERS ................................................................................................. 3 ABSTRACT ............................................................................................................................... 5 SAMMANFATTNING .............................................................................................................. 7 ABBREVIATIONS .................................................................................................................... 9 INTRODUCTION .................................................................................................................... 11 The immune system ............................................................................................................. 11 The innate immune system ............................................................................................... 11 The adaptive immune system ........................................................................................... 13 The mucosal/gut immune system ..................................................................................... 18 Oral tolerance ................................................................................................................... 20 Probiotics .......................................................................................................................... 21 Infant immunity ................................................................................................................ 22 Celiac disease (CD) .............................................................................................................. 23 History .............................................................................................................................. 23 Genetic factors .................................................................................................................. 23 Environmental factors ...................................................................................................... 24 Symptoms ......................................................................................................................... 24 Diagnosis .......................................................................................................................... 27 Histopathology ................................................................................................................. 27 Serologic markers ............................................................................................................. 29 HLA typing ...................................................................................................................... 30 Epidemiology ................................................................................................................... 30 Development of CD/(Molecular) Pathogenesis ............................................................... 31 Treatment ......................................................................................................................... 35 Associated diseases .......................................................................................................... 36 Mortality & malignancy ................................................................................................... 36 Type 1 diabetes (T1D) .......................................................................................................... 37 History .............................................................................................................................. 37 Definition & Symptoms ................................................................................................... 38 Diagnosis .......................................................................................................................... 38 Genetic factors .................................................................................................................. 38 Environmental factors ...................................................................................................... 39 Serologic markers ............................................................................................................. 42 Epidemiology ................................................................................................................... 43 Development of T1D/(Molecular) Pathogenesis .............................................................. 44 Treatment ......................................................................................................................... 45 Associated diseases .......................................................................................................... 45 Mortality & Complications .............................................................................................. 46 Intervention & prevention studies in T1D ........................................................................ 46 AIMS OF THE THESIS .......................................................................................................... 49 MATERIAL & METHODS ..................................................................................................... 51 Study subjects ....................................................................................................................... 51 Paper I .............................................................................................................................. 51 Paper II ............................................................................................................................. 51 Paper III ............................................................................................................................ 52 Paper IV ............................................................................................................................ 53 Laboratory methods .............................................................................................................. 54 1 Sample collection (paper I-IV) ......................................................................................... 54 RNA isolation (Paper I-IV) .............................................................................................. 55 Real-time polymerase chain reaction (PCR)-array analyses (Paper I, III and IV) ........... 56 Quantitative real time reverse transcription (RT)-PCR analyses (Paper II and III) ......... 59 Immunohistochemical analyses (Paper II) ....................................................................... 60 Cytokine assessment in in vitro cultured biopsies (Paper II) ........................................... 61 Analyses of apoptotic markers in IL-17 treated Caco-2 cells (Paper II) .......................... 61 Analyses of T1D related autoantibodies (Paper IV) ........................................................ 61 Whole blood cultures in vitro stimulated with LPS or LTA (Paper IV) .......................... 62 Flow cytometric analyses (Paper IV) ............................................................................... 62 Analyses of C-reactive protein (CRP) (Paper IV) ............................................................ 62 Statistical methods ................................................................................................................ 62 PCA .................................................................................................................................. 63 Clustering ........................................................................................................................
Load more

Recommended publications
  • Historial Perspectives in Translational Medicine
    Historial Perspectives in Translational Medicine Willem Dicke. Brilliant Clinical Observer and Translational Investigator. Discoverer of the Toxic Cause of Celiac Disease David Yan 1 and Peter R. Holt , M.D. 2 Abstract We can admire and learn from physicians with acute clinical acumen and superb approaches to translational research. The observations and studies of Dr. Willem Dicke, a Dutch pediatrician, on the toxic effects of a protein component of wheat and rye demonstrate the highest quality of such investigations. From a clinical observation of one child with celiac disease, through years of historical questioning and empirical dietary suggestions of patient families, he concluded that such foods were toxic. When research became possible after the second world war and fecal fat measures as a hard end point became available he studied 5 children in detail to establish the validity of his clinical clues. Keywords: celiac disease , translational research , diet Progress in defining clinical disorders often requires the One dietary approach was to reduce or eliminate dietary fat combination of careful observations of the patient’s disease, since the stools of patients had a greatly increased fat content. intuition and the ability to perform the clinical translational However, such diets were calorically severely defi cient. Other research to prove a hypothesis. Th e story of William Dicke, a clinical observation stimulated the conclusion that carbohydrate Dutch pediatrician, who had the birth of an idea from a case ingestion increased the weight and water contents of the stools.6 report from listening to his child patients’ mothers, who then Improvement in patients was noted when carbohydrates, including continued clinical questioning of families with children with wheat products, were omitted from the diet; 7 however, clinicians the disease for almost a decade and then wrote his thesis on a also reduced ingested fat to lower fecal fat content, a calorically remarkably careful series of clinical studies which resulted in insuffi cient diet.
    [Show full text]
  • Celiac Disease: It's Autoimmune Not an Allergy
    CELIAC DISEASE: IT’S AUTOIMMUNE NOT AN ALLERGY! Analissa Drummond PA-C Department of Pediatrics Division of Pediatric Gastroenterology HISTORY OF CELIAC DISEASE Also called gluten-sensitive enteropathy and nontropical spue First described by Dr. Samuel Gee in a 1888 report entitled “On the Coeliac Affection” Term “coeliac” derived from Greek word koiliakaos-abdominal Similar description of a chronic, malabsorptive disorder by Aretaeus from Cappadochia ( now Turkey) reaches as far back as the second century AD HISTORY CONTINUED The cause of celiac disease was unexplained until 1950 when the Dutch pediatrician Willem K Dicke recognized an association between the consumption of bread, cereals and relapsing diarrhea. This observation was corroborated when, during periods of food shortage in the Second World War, the symptoms of patients improved once bread was replaced by unconventional, non cereal containing foods. This finding confirmed the usefulness of earlier empirical diets that used pure fruit, potatoes, banana, milk, or meat. HISTORY CONTINUED After the war bread was reintroduced. Dicke and Van de Kamer began controlled experiments by exposing children with celiac disease to defined diets. They then determined fecal weight and fecal fat as a measure of malabsorption. They found that wheat, rye, barley and to a lesser degree oats, triggered malabsorption, which could be reversed after exclusion of the “toxic” cereals from the diet. Shortly after, the toxic agents were found to be present in gluten, the alcohol-soluble fraction of wheat protein. PATHOPHYSIOLOGY Celiac disease is a multifactorial, autoimmune disorder that occurs in genetically susceptible individuals. Trigger is an environmental agent-gliadin component of gluten.
    [Show full text]
  • Samuel Gee, Aretaeus, and the Coeliac Affection
    BRITISH MEDICAL JOURNAL 6 APRIL 1974 Medical History Br Med J: first published as 10.1136/bmj.2.5909.45 on 6 April 1974. Downloaded from Samuel Gee, Aretaeus, and The Coeliac Affection BRYAN DOWD, JOHN WALKER-SMITH British Medicaljournal, 1974, 2, 45-47 Introduction Last year the Royal Hospital of Saint Bartholomew in London celebrated the 850th anniversary of its founding by Rahere in 1123. Over the centuries many distinguished physicians and surgeons have been members of its sitaff bu-t to paediatricians and gastroenterologists today it is Samuel Jones Gee whose name is most likely to be familiar (see photograph) because of his contribution to paediatrics.1 Gee was born in London in 1839 and died at Keswick in 1911. He was a man with a deep love of the past and a passion for the accurate use of words, which, he had learnt, led ito accurate (thinking and caused fewer mistakes than fall to the lot of most mortal men. In 1888 he wrote in St. Bartholomew's Hospital Reports2 a notable account of What he chose to call the coeliac affection, which remain.s one of the most vivid and accurate descriptions of the clinical state which we still call coeliac disease. It seems very likely that the title he selected reflected his admiration for (the work of a colleague recorded in Greek http://www.bmj.com/ nearly two thousand years earlier. Gee, it is said, was often amused to find that some contemporary observation had been long since a writer of former times. In this Samuel Jones Gee, 1839-1911.
    [Show full text]
  • Samuel Gee, Aretaeus, and the Coeliac Affection
    BRITISH MEDICAL JOURNAL 6 APRIL 1974 Medical History Samuel Gee, Aretaeus, and The Coeliac Affection BRYAN DOWD, JOHN WALKER-SMITH British Medicaljournal, 1974, 2, 45-47 Introduction Last year the Royal Hospital of Saint Bartholomew in London celebrated the 850th anniversary of its founding by Rahere in 1123. Over the centuries many distinguished physicians and surgeons have been members of its sitaff bu-t to paediatricians and gastroenterologists today it is Samuel Jones Gee whose name is most likely to be familiar (see photograph) because of his contribution to paediatrics.1 Gee was born in London in 1839 and died at Keswick in 1911. He was a man with a deep love of the past and a passion for the accurate use of words, which, he had learnt, led ito accurate (thinking and caused fewer mistakes than fall to the lot of most mortal men. In 1888 he wrote in St. Bartholomew's Hospital Reports2 a notable account of What he chose to call the coeliac affection, which remain.s one of the most vivid and accurate descriptions of the clinical state which we still call coeliac disease. It seems very likely that the title he selected reflected his admiration for (the work of a colleague recorded in Greek nearly two thousand years earlier. Gee, it is said, was often amused to find that some contemporary observation had been long since a writer of former times. In this Samuel Jones Gee, 1839-1911. (Reproduced by permission anticipated by of the Royal College of Physicians of London.) instance, we believe, he chose -to be anticipated by the physician Aretaeus the Cappadocian, who with others, had described tthe coeliac statte.
    [Show full text]
  • All About Gluten & Celiac Disease
    College of Agricultural, Consumer and Environmental Sciences All About Discovery! ™ New Mexico State University aces.nmsu.edu All about Gluten? Celiac disease, gluten sensitivity, wheat sensitivity, and other Dr. Raquel Garzon, RDN NMSU Cooperative Extension Services considerations Nutrition and Wellness State Specialist About the College: The College of Agricultural, Consumer and Environmental Sciences is an engine for economic and community development in New Mexico, improving the lives of New Mexicans through academic, research, and extension programs. All About Discovery! ™ New Mexico State University aces.nmsu.edu All About Discovery! ™ New Mexico State University aces.nmsu.edu Definitions Gluten: A heterogenous mix of water-insoluble storage proteins in cereal grains, wheat, rye, and barley, that gives dough its elastic properties; it consists of two fractions: prolamins and glutelins; the fractions of wheat are gliadins and glutenins Prolamins: Difficult to digest; the high content of proline and glutamine content in gluten that prevents complete breakdown by digestive enzymes; this is the component that causes issues in celiac disease Gliadin: The prolamin in wheat Secalin: The prolamin in rye Hordein: The prolamin in barley Avenin: The prolamin in oats FODMAPs: Fermentable Oligo-, Di-, and Mono-saccharides And Polyols; short chain carbohydrates poorly absorbed in the small intestine; osmotically active and highly fermentable by gut bacteria 2016 REVITALIZE PROJECT, INC. All About Discovery! ™ New Mexico State University aces.nmsu.edu
    [Show full text]
  • INSIGHTS INTO the MOLECULAR GENETICS of CELIAC DISEASE: Applying Family- and Population-Based Strategies
    Helsinki University Biomedical Dissertations No. 128 INSIGHTS INTO THE MOLECULAR GENETICS OF CELIAC DISEASE: applying family- and population-based strategies Lotta Koskinen Department of Medical Genetics and Research Program for Molecular Medicine University of Helsinki Helsinki, Finland ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Medicine, University of Helsinki, for public examination in Lecture Hall 3, Biomedicum Helsinki 1, Haartmaninkatu 8, Helsinki, on September 25th 2009, at 12 noon. Helsinki 2009 Supervisors: Päivi Saavalainen, Ph.D. Department of Medical Genetics, and Research Program for Molecular Medicine University of Helsinki, Helsinki, Finland and Juha Kere, M.D., Ph.D. Department of Medical Genetics University of Helsinki, Helsinki, Finland and Folkhälsan Institute of Genetics Helsinki, Finland and Department of Biosciences and Nutrition at Novum Karolinska Institutet, Huddinge, Sweden Reviewers: Katarina Pelin, Ph.D. Department of Biological and Environmental Sciences Division of Genetics University of Helsinki, Helsinki, Finland and Outi Vaarala, M.D., Ph.D. Immune Response Unit Department of Vaccination and Immune Protection National Institute for Health and Welfare, Helsinki, Finland Opponent: Jose Ramón Bilbao, Ph.D. Immunogenetics Research Laboratory Hospital de Cruces, Barakaldo, Spain and Department of Genetics, Physical Anthropology and Animal Physiology University of the Basque Country, Spain Yliopistopaino ISSN 1457-8433 Helsinki 2009 ISBN 978-952-10-5701-4 (print) ISBN 978-952-10-5702-1 (PDF) TO MY FAMILY Mikä onkaan suurempaa kuin löytää ratkaisematon arvoitus kummallisine piirteineen? Edith Södergran (suom. Uuno Kailas) What could be greater than the strange features of a riddle unsolved? Edith Södergran (translated by Gounil Brown) Table of contents List of original publications 6 Abbreviations 7 Abstract 8 Introduction 9 Review of the literature 10 1.
    [Show full text]
  • A History of Celiac Disease
    Chapter 2 A History of Celiac Disease Víctor M. García-Nieto History of Pediatrics Group Coordinator of the Spanish Pediatric Associaton. Pediatrics Service of Nuestra Señora de Candelaria Hospital, Santa Cruz de Tenerife, Spain. [email protected] Doi: htp://dx.doi.org/10.3926/oms.226 How to cite this chapter García Nieto VM. A History of Celiac Disease. In Rodrigo L and Peña AS, editors. Celiac Disease and Non-Celiac Gluten Sensitvity. Barcelona, Spain: OmniaScience; 2014. p. 45-59. 45 V.M.García Nieto Abstract Celiac disease is known since ancient tmes. This chapter describes Aretaeus of Cappadocia’s contributon, approximately 2,000 years ago and up untl recent tmes when Marcelo Royer in Buenos Aires and Margot Shiner in London each independently designed a technique for peroral duodenal biopsy under fuoroscopic control. Over the centuries, doctors tried to treat this disease using diferent diets since the exact pathogenesis of CD was not clear. Special atenton is given to the early history of celiac disease in Spain, highlightng the work of Santago Cavengt and later writngs by other Spanish doctors. The elucidaton of the cause of celiac disease is due to Willem Karel Dicke. He published his frst fndings in 1941 in a Dutch Journal in an age when medical literature was based on the empirical knowledge that the diets by proposed by Fanconi and Haas were best for the treatment of the disease. The introducton of intestnal biopsy was the key in confrming the diagnosis of celiac disease since it revealed the characteristc fatening of the mucosa exposed to gluten and the response to a gluten-free diet.
    [Show full text]
  • Type 1 Diabetes and Autoimmune Polyglandular Syndrome: a Clinical Review
    REVIEW type 1 diabetes and autoimmune polyglandular syndrome: a clinical review A. Van den Driessche, V. Eenkhoorn, L. Van Gaal, C. De Block* Department of Diabetology and Endocrinology, Antwerp University Hospital, Edegem, Belgium, *corresponding author: tel.: 32-3-821 32 78, fax: 32-3-825 49 80, e-mail: [email protected] abstraCt Keywords type 1 diabetes mellitus (t1dM) results from autoimmune Autoantibodies, autoimmune polyglandular syndrome, destruction of insulin-producing β cells and is characterised type 1 diabetes mellitus by the presence of insulitis and β-cell autoantibodies. up to one third of patients develop an autoimmune polyglandular syndrome. fifteen to 30% of t1dM subjects introduCtion have autoimmune thyroid disease (hashimoto’s or graves’ disease), 5 to 10% are diagnosed with autoimmune gastritis Type 1 diabetes mellitus (T1DM), arising through a complex and/or pernicious anaemia (AIG/PA), 4 to 9% present interaction of immune, genetic and environmental factors, with coeliac disease (Cd), 0.5% have addison’s disease results from autoimmune destruction of insulin-producing (AD), and 2 to 10% show vitiligo. these diseases are β cells. T1DM is characterised by the appearance of characterised by the presence of autoantibodies against insulitis and the presence of β-cell autoantibodies.1 In up to thyroid peroxidase (for hashimoto’s thyroiditis), TSH one third of patients the autoimmune attack is not limited receptor (for graves’ disease), parietal cell or intrinsic to β cells, but expands into an autoimmune polyglandular factor (for AIG/PA), tissue transglutaminase (for Cd), syndrome.2-8 Of type 1 diabetic subjects, 15 to 30% have and 21-hydroxylase (for AD).
    [Show full text]
  • A Brief History of Celiac Disease Long, Long Ago, Man Was a Simple Hunter/Gatherer
    SUMMER 2007 | VOL 7 ISSUE 3 A PUBLICATION OF THE UNIVERSITY OF CHICAGO CELIAC DISEASE CENTER IMPROVING LIVES THROUGH AWARENESS, impact EDUCATION, AND RESEARCH A Brief History of Celiac Disease Long, long ago, man was a simple hunter/gatherer. His diet consisted of fruits, nuts, perhaps tubers and the occasional feast of meat. But eventually, he learned to cultivate plants, and the agricultural revolution began. Soon, the hunter/gatherer way of life was replaced by domestication of crops and animals. As habits changed, some unanticipated adults causing malnutrition and characterized problems arose. The human gut had developed, by a gas-distended abdomen. He even went on over more than 2 million years, into a to suggest dietetic treatment, writing: “ Some sophisticated organ that could tolerate food patients have appeared to derive considerable antigens that were staples of the human diet over advantage from living almost entirely upon hundreds of thousands of years. But how would rice.” Baillie’s observations, however, went Dr. Stefano Guandalini, M.D. it react to new antigens, suddenly appearing practically unnoticed, and it was for the in the diet? The agricultural revolution of the English doctor Samuel Gee, a leading authority the damage to the intestinal mucosa. Yet some Neolithic period generated a whole battery of in pediatric diseases, to take full credit for the of the present-day findings, which we tend food antigens previously unknown to man, modern description of celiac disease some 75 to consider as recent advances, were indeed including protein from cow, goat, and donkey years later, when he gave a lecture to medical well known long ago, including that celiac milk, as well as birds’ eggs and cereals.
    [Show full text]
  • The Gluten-Free Diet: Medically Required Or Just a Fad?
    Smart Choice for a Healthy Life Vol. 3, No. 2 The Gluten-Free Diet: Medically Required or Just A Fad? By Shelly Asplin, MA, RD, LMNT Does it seem that at every turn someone new is following the Second, the health care practitioner will request a small bowel gluten-free diet? It is true that many people are following the biopsy. For patients with dermatitis herpetiformis, the practitioner gluten-free diet as a fad. But for those with celiac disease (CD) will request skin biopsies. or non-celiac gluten sensitivity (NCGS), the gluten-free diet is a Third, the practitioner will recommend implementation of the medical requirement. gluten-free diet based on the findings of blood work and biopsies. The diagnosis of celiac disease is confirmed when symptoms A Brief History of Celiac Disease and NCGS subside and the intestinal lining normalizes while the patient is on Celiac disease was first described by a Greek physician in 150 a gluten-free diet. A.D.1,2 The connection between celiac disease and dietary manage- ment was not made until 1888 when Samuel Gee, a British physi- An estimated three million people have celiac cian, stated “If the patient can be cured at all, it must be by means of diet.”3 Dietitians most certainly appreciate Gee’s acknowledgement disease and 18 million are thought to have NCGS. of medical nutrition therapy as the sole treatment for celiac disease. Currently, there is no standard diagnostic approach or validated More recently the role of medical nutrition therapy in NCGS is blood tests available for the diagnosis of non-celiac gluten sensi- becoming more mainstream.
    [Show full text]
  • Impact of Coeliac Disease on the Partner's Diet- No Altruism
    ition & F tr oo u d N f S o c l i e a n n c Hettiarachchi et al., J Nutr Food Sci 2012, 2:3 r e u s o J Journal of Nutrition & Food Sciences DOI: 10.4172/2155-9600.1000135 ISSN: 2155-9600 Research Article Open Access Impact of Coeliac Disease on the Partner’s diet- No Altruism Irasha Thulani Hettiarachchi1*, David Rowbotham2, Gillian Swift3, Rosemary Crimmins3, Megan Gallagher4 and Chris Probert5 1Waikato Hospital, Pembroke Street, Private Bag 3200, Hamilton 3240, New Zealand 2Department of Gastroenterology and Hepatology, Auckland City Hospital, Private Bag 92024, Auckland Mail Centre, Auckland 1142, New Zealand 3University Hospitals Llandough, Penlan Road, Penarth, Cardiff, CF64 2XX, United Kingdom 4University Hospitals Birmingham, Birmingham, United Kingdom 5Professor of Gastroenterology, University of Liverpool, United Kingdom Abstract Background: Coeliac disease is an autoimmune disorder characterised by intolerance to gluten in genetically susceptible individuals. Withdrawal of dietary gluten remains the only effective treatment at present. Aim: To investigate whether partners of patients with coeliac disease adopt a gluten-free diet to support the patients and to assess the impact of gender on dietary concordance. Methods: A pilot case-control study was carried out at university teaching hospitals in Auckland, New Zealand and Cardiff, United Kingdom. 38-item dietary questionnaires were completed by patients, controls and their partners. The discordance between the diet of patients or controls and their partners was compared and Student’s t -test applied to the results. Results: The discordance scores were significantly greater in case couples than in control couples. (16.6-female patient couples, 15.1-male patient couples versus 6.2-control couples; p<0.00003).
    [Show full text]
  • Recent Advances in Coeliac Disease
    n COLLEGE LECTURES Recent advances in coeliac disease Paul J Ciclitira This article is ABSTRACT – Coeliac disease, or gluten-sensitive from the word coelom meaning the body cavity. The based on a enteropathy, affects 1 in 100–200 people in the condition was first formally described by Samuel Gee regional College UK. The condition, which is exacerbated by in 1888 in his manuscript in the St Bartholomew’s lecture given at wheat, rye, barley and possibly oats, can be Hospital reports. He described it as a wasting Leicester General treated with a gluten-free diet in which these condition, predominately affecting children, with Hospital on 19 cereals are omitted. Serological screening, partic- diarrhoea resulting in weight loss, immaciation and March 2002 by ularly of high-risk groups, with both IgA and IgG 1 Paul J Ciclitira ultimately death. The disorder at that time was MD PhD FRCP , based systems can be used to identify cases. noted to have a 20% mortality rate. Samuel Gee Professor of Diagnosis depends on the use of a small reported that the condition must be cured by means Gastroenterology, intestinal biopsy, which reveals the classical of the diet and, indeed, had noted that a child thrived Guy’s and changes of loss of the normal villous architecture. wonderfully on a diet of nothing but mussels. St Thomas’ Evidence suggests that gluten-sensitive T cells However, the child reported that he would rather die Hospital, London are involved in the pathogenesis of the disease. than continue to eat mussels for a second season. Use of in vitro systems has suggested an immuno- Coeliac disease remains under-diagnosed.
    [Show full text]